Saqer Alkharabsheh, MD
Cardiovascular Disease · Englewood, OHNPI 1568802973
Payments from drug & device makers
Across 87 payments — averaging $575.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$30K
- Abbott$10K
- Boston Scientific$8K
- Baylis Medical Company Inc$1K
- Biosense Webster, Inc.$550
- Medical Device Business Services, Inc.$59
- plus $39 from 2 others
What the payments were for
- Grants$40,00080%
- Travel & lodging$6,11712%
- Food & beverage$3,3667%
- Education$5751%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 42 | $30,071 |
| Abbott | 5 | $10,408 |
| Boston Scientific | 20 | $7,803 |
| Baylis Medical Company Inc | 6 | $1,127 |
| Biosense Webster, Inc. | 10 | $550 |
| Medical Device Business Services, Inc. | 2 | $59 |
| Atricure, Inc. | 1 | $24 |
| Cardiva Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM MRI S-ICD$5,000
- VersaCross Access Solution$1,844
- AFFERA MAPPING SYSTEM$1,585
- Micra$1,021
- WATCHMAN Access System$784
- Arctic Front$776
- TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)$374
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$253
- Carto 3$216
- ARCTIC FRONT ADVANCE$146
- S-ICD System Magnet$124
- GENERAL EP$110
- ENSITE PRECISION$107
- S ICD$106
How this compares
$50,057 in reported general payments places this provider in the 85th percentile of 827 cardiovascular disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 228 | $208,088 |
| XareltoRivaroxaban | 28 | $31,673 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 27 | $6,766 |
| Amiodarone Hcl | 73 | $3,974 |
| Dofetilide | 18 | $1,548 |
| Midodrine Hcl | 18 | $1,519 |
| Flecainide Acetate | 31 | $999 |
| Metoprolol Succinate | 63 | $595 |
| ClopidogrelClopidogrel Bisulfate | 38 | $486 |
| Metoprolol Tartrate | 112 | $425 |
| SotalolSotalol Hcl | 20 | $323 |
| Pantoprazole Sodium | 28 | $227 |
| Carvedilol | 36 | $225 |
| Losartan Potassium | 29 | $222 |
| Warfarin Sodium | 13 | $196 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Englewood
- Samir KapadiaCleveland$11.1M
- Steven NissenCleveland$5.3M
- Milind DesaiCleveland$5M
- Abraham LincoffCleveland$3.6M
- Carlos HubbardCleveland$3.1M
- Guilherme AttizzaniCleveland$2.8M
- Wai Hong TangCleveland$2.2M
- Bhola RamaMarion$2.1M
- Mazen HannaCleveland$1.6M
- Akber MohammedSpringfield$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.